Synthesis and Mechanism of p53-MDM2 Inhibitors with Heterocyclic Structures: A Focused Review

被引:0
|
作者
Ji, Li-Tao [1 ]
Zhang, Wenjing [1 ]
Zhang, Yi [1 ]
Zhao, Su [1 ]
Long, Hai-Tao [1 ]
Qin, Li-Qing [1 ]
Tian, Jia-Cheng [1 ]
Li, Hong-Zhang [1 ]
Zhu, Dan-Xue [1 ]
Zhou, Yan [1 ]
Lu, Yi-Duo [1 ]
Wang, Zhen-Chao [1 ,2 ,3 ]
Li, Cheng-Peng [1 ,2 ,3 ]
机构
[1] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China
[2] Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550025, Peoples R China
[3] Guizhou Univ, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Peoples R China
来源
CHEMISTRYSELECT | 2023年 / 8卷 / 45期
关键词
Small molecule; heterocyclic compounds; p53-MDM2; cancer; synthesis method; SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; BIOLOGICAL EVALUATION; MDM2; INHIBITORS; SPIRO-OXINDOLES; CLINICAL-TRIALS; P53; PATHWAY; POTENT; DISCOVERY;
D O I
10.1002/slct.202302240
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
P53 gene mutation is one of the important causes in tumors. p53-MDM2 (murine double minute 2) inhibitors can interrupt p53-dependent gene transcription activity, and inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this article, we focused on the synthesis methods about nutlins and other p53 small molecule inhibitors, in order to find potential new structure for novel p53 small molecule inhibitor synthesizing. Mutation of the p53 gene is among the most important causes of tumors. Inhibitors of p53-MDM2 can impede p53-dependent gene transcription, inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this review we discuss the synthesis of nutlins and other small-molecule p53 inhibitors, with an aim to inspire new structures and methods for the synthesis of future small-molecule p53 inhibitors.+image
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Recent Advances of p53-MDM2 Small Molecule Inhibitors (2011-Present)
    Lv, Peng-Cheng
    Sun, Juan
    Zhu, Hai-Liang
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 618 - 626
  • [2] Design, Synthesis and Biological Evaluation of Sulfamide and Triazole Benzodiazepines as Novel p53-MDM2 Inhibitors
    Yu, Zhiliang
    Zhuang, Chunlin
    Wu, Yuelin
    Guo, Zizhao
    Li, Jin
    Dong, Guoqiang
    Yao, Jianzhong
    Sheng, Chunquan
    Miao, Zhenyuan
    Zhang, Wannian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09): : 15741 - 15753
  • [3] p53-MDM2 and MDMX Antagonists
    Neochoritis, Constantinos
    Estrada-Ortiz, Natalia
    Khoury, Kareem
    Domling, Alexander
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 167 - 187
  • [4] Design, synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors
    Si, Dongjuan
    Luo, Huijuan
    Zhang, Xiaomeng
    Yang, Kundi
    Wen, Hongmei
    Li, Wei
    Liu, Jian
    BIOORGANIC CHEMISTRY, 2021, 115
  • [5] Patented inhibitors of p53-Mdm2 interaction (2006-2008)
    Weber, Lutz
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (02) : 179 - 191
  • [6] Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction
    Vaupel, Andrea
    Bold, Guido
    De Pover, Alain
    Stachyra-Valat, Therese
    Hergovich-Lisztwan, Joanna
    Kallen, Joerg
    Masuya, Keiichi
    Furet, Pascal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2110 - 2114
  • [7] Synthesis and cytotoxicity of novel dispiro derivatives of 5-arylidenoxazolones, potential inhibitors of p53-MDM2 protein-protein interaction
    Beloglazkina, A. A.
    Skvortsov, D. A.
    Tafeenko, V. A.
    Majouga, A. G.
    Zyk, N. V.
    Beloglazkina, E. K.
    RUSSIAN CHEMICAL BULLETIN, 2018, 67 (03) : 562 - 569
  • [8] Recent Small-Molecule Inhibitors of the p53-MDM2 Protein-Protein Interaction
    Beloglazkina, Anastasia
    Zyk, Nikolai
    Majouga, Alexander
    Beloglazkina, Elena
    MOLECULES, 2020, 25 (05):
  • [9] An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors
    Tortorella, Paolo
    Laghezza, Antonio
    Durante, Milena
    Gomez-Monterrey, Isabel
    Bertamino, Alessia
    Campiglia, Pietro
    Loiodice, Fulvio
    Daniele, Simona
    Martini, Claudia
    Agamennone, Mariangela
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (06) : 1216 - 1227
  • [10] Artificial Macrocycles as Potent p53-MDM2 Inhibitors
    Estrada-Ortiz, Natalia
    Neochoritis, Constantinos G.
    Twarda-Clapa, Aleksandra
    Musielak, Bogdan
    Holak, Tad A.
    Domling, Alexander
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (10): : 1025 - 1030